WO1995020039A3 - Customized proteases with altered transacylation activity - Google Patents
Customized proteases with altered transacylation activity Download PDFInfo
- Publication number
- WO1995020039A3 WO1995020039A3 PCT/US1995/006682 US9506682W WO9520039A3 WO 1995020039 A3 WO1995020039 A3 WO 1995020039A3 US 9506682 W US9506682 W US 9506682W WO 9520039 A3 WO9520039 A3 WO 9520039A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proteases
- transacylation
- customized
- methods
- amino acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth-hormone releasing factors (GH-RF) (Somatoliberin)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU26513/95A AU679861B2 (en) | 1993-10-28 | 1994-10-28 | Customized proteases with altered transacylation activity |
JP7517672A JPH09504438A (en) | 1993-10-28 | 1994-10-28 | Special protease with modified acyl transfer activity |
NZ283995A NZ283995A (en) | 1993-10-28 | 1994-10-28 | Customized (mutant) carboxypeptidase Y having modified S1 subsite |
EP95921432A EP0723585A1 (en) | 1993-10-28 | 1994-10-28 | Customized proteases |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14470493A | 1993-10-28 | 1993-10-28 | |
US08/144,704 | 1994-10-27 | ||
US08/329,892 | 1994-10-27 | ||
US08/329,892 US6187579B1 (en) | 1993-10-28 | 1994-10-27 | Customized proteases |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1995020039A2 WO1995020039A2 (en) | 1995-07-27 |
WO1995020039A3 true WO1995020039A3 (en) | 1996-03-21 |
WO1995020039B1 WO1995020039B1 (en) | 1996-05-30 |
Family
ID=26842276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/006682 WO1995020039A2 (en) | 1993-10-28 | 1994-10-28 | Customized proteases with altered transacylation activity |
Country Status (7)
Country | Link |
---|---|
US (2) | US6187579B1 (en) |
EP (1) | EP0723585A1 (en) |
JP (1) | JPH09504438A (en) |
AU (1) | AU679861B2 (en) |
CA (1) | CA2174525A1 (en) |
NZ (1) | NZ283995A (en) |
WO (1) | WO1995020039A2 (en) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9323429D0 (en) * | 1993-11-12 | 1994-01-05 | Wellcome Found | Therapy |
NZ315713A (en) * | 1995-08-16 | 1999-08-30 | Zeneca Ltd | A conjugate comprising an antibody as targeting moiety linked to a carboxypeptidase b (cpb) |
DE19535082A1 (en) | 1995-09-21 | 1997-03-27 | Henkel Ecolab Gmbh & Co Ohg | Paste-like detergent and cleaning agent |
US6537776B1 (en) | 1999-06-14 | 2003-03-25 | Diversa Corporation | Synthetic ligation reassembly in directed evolution |
US20030219752A1 (en) * | 1995-12-07 | 2003-11-27 | Diversa Corporation | Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof |
US6562594B1 (en) | 1999-09-29 | 2003-05-13 | Diversa Corporation | Saturation mutagenesis in directed evolution |
US6171820B1 (en) | 1995-12-07 | 2001-01-09 | Diversa Corporation | Saturation mutagenesis in directed evolution |
US6238884B1 (en) | 1995-12-07 | 2001-05-29 | Diversa Corporation | End selection in directed evolution |
US6939689B2 (en) | 1995-12-07 | 2005-09-06 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
US20020164580A1 (en) * | 1995-12-07 | 2002-11-07 | Diversa Corporation | Combinatorial screening of mixed populations of organisms |
US20040023327A1 (en) * | 1995-12-07 | 2004-02-05 | Short Jay M. | End selection in directed evolution |
US6361974B1 (en) | 1995-12-07 | 2002-03-26 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
US6713279B1 (en) | 1995-12-07 | 2004-03-30 | Diversa Corporation | Non-stochastic generation of genetic vaccines and enzymes |
US5830696A (en) | 1996-12-05 | 1998-11-03 | Diversa Corporation | Directed evolution of thermophilic enzymes |
US6764835B2 (en) * | 1995-12-07 | 2004-07-20 | Diversa Corporation | Saturation mutageneis in directed evolution |
US7018793B1 (en) | 1995-12-07 | 2006-03-28 | Diversa Corporation | Combinatorial screening of mixed populations of organisms |
US6740506B2 (en) | 1995-12-07 | 2004-05-25 | Diversa Corporation | End selection in directed evolution |
US6352842B1 (en) | 1995-12-07 | 2002-03-05 | Diversa Corporation | Exonucease-mediated gene assembly in directed evolution |
US6358709B1 (en) | 1995-12-07 | 2002-03-19 | Diversa Corporation | End selection in directed evolution |
DE19636035A1 (en) | 1996-09-05 | 1998-03-12 | Henkel Ecolab Gmbh & Co Ohg | Paste-like detergent and cleaning agent |
CA2269659A1 (en) * | 1996-11-04 | 1998-05-14 | Merck Frosst Canada & Co. | Hydrolase binding assay |
DE19703364A1 (en) | 1997-01-30 | 1998-08-06 | Henkel Ecolab Gmbh & Co Ohg | Paste-like detergent and cleaning agent |
US5985627A (en) * | 1997-02-28 | 1999-11-16 | Carlsberg Laboratory | Modified carboxypeptidase |
US6908757B1 (en) | 1998-03-26 | 2005-06-21 | The Procter & Gamble Company | Serine protease variants having amino acid deletions and substitutions |
US6461834B1 (en) * | 1998-11-06 | 2002-10-08 | Bionebraska, Inc. | Clostripain catalyzed amidation of peptides |
DE19857687A1 (en) | 1998-12-15 | 2000-06-21 | Henkel Ecolab Gmbh & Co Ohg | Pasty detergent |
US20090130718A1 (en) * | 1999-02-04 | 2009-05-21 | Diversa Corporation | Gene site saturation mutagenesis |
JP2003505067A (en) | 1999-07-22 | 2003-02-12 | ザ、プロクター、エンド、ギャンブル、カンパニー | Subtilisin protease variants with amino acid deletions and substitutions in specific epitope regions |
CZ2002212A3 (en) | 1999-07-22 | 2002-07-17 | The Procter & Gamble Company | Variants of subtilisin protease having amino acid substitutions in defined epitope regions |
US6946128B1 (en) | 1999-07-22 | 2005-09-20 | The Procter & Gamble Company | Protease conjugates having sterically protected epitope regions |
CZ2002171A3 (en) | 1999-07-22 | 2002-06-12 | The Procter & Gamble Company | Proteinase conjugate, cleansing agent and preparation for personal hygiene |
CN1100789C (en) * | 2000-01-13 | 2003-02-05 | 中国人民解放军第二军医大学 | Preparation process of gene recomibination calcitonin or calcitonin analog |
US20030170846A1 (en) * | 2000-04-24 | 2003-09-11 | Weisgerber David John | Enzyme variants having one or more D-amino acid substitutions |
ATE321778T1 (en) * | 2000-09-04 | 2006-04-15 | Cellpep Sa | MAUROTOXIN, PI1 AND HSTX1 DERIVATIVES |
US20040009498A1 (en) * | 2002-01-14 | 2004-01-15 | Diversa Corporation | Chimeric antigen binding molecules and methods for making and using them |
US20030219854A1 (en) * | 2002-03-21 | 2003-11-27 | Micrologix Biotech Inc. | Methods for producing modified anti-infective peptides |
US20040171070A1 (en) * | 2002-05-20 | 2004-09-02 | Ramagauri Bhikhabhai | Peptide analysis using a solid support |
DE602005008071D1 (en) * | 2004-08-13 | 2008-08-21 | Hoffmann La Roche | C-TERMINAL MODIFICATION OF POLYPEPTIDES |
DK1794294T3 (en) * | 2004-09-27 | 2011-10-31 | Sanofi Aventis Deutschland | Recombinant carboxypeptidase B |
EP1979370B1 (en) * | 2006-01-17 | 2010-03-17 | N.V. Organon | SELECTIVE ENZYMATIC HYDROLYSIS OF C-TERMINAL tert-BUTYL ESTERS OF PEPTIDES |
WO2011018421A1 (en) * | 2009-08-10 | 2011-02-17 | Morphosys Ag | Novel screening strategies for the identification of binders |
EP2847316A1 (en) | 2012-05-11 | 2015-03-18 | Novozymes A/S | A brewing method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0085516A2 (en) * | 1982-01-22 | 1983-08-10 | Carlsberg Biotechnology Ltd. A/S | A process for enzymatic replacement of the B-30 amino acid in insulins |
WO1992002615A1 (en) * | 1990-08-09 | 1992-02-20 | Genentech, Inc. | Serine protease variants having peptide ligase activity |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RO80806A (en) | 1979-04-06 | 1983-02-01 | De Forenede Bryggerier As,Dk | PROCEDURE FOR ENZYMATIC OBTAINING PEPTIDES |
US5185258A (en) | 1984-05-29 | 1993-02-09 | Genencor International, Inc. | Subtilisin mutants |
US4959312A (en) * | 1985-05-31 | 1990-09-25 | The University Of Tennessee Research Corporation | Full spectrum mutagenesis |
JPH07121222B2 (en) | 1987-03-24 | 1995-12-25 | 寶酒造株式会社 | Chemically modified serine protease-containing composition, its production method and use |
GB8807271D0 (en) | 1988-03-26 | 1988-04-27 | Preece A W | Cell fusion apparatus |
US5049656A (en) | 1988-12-21 | 1991-09-17 | Board Of Regents Of The University Of Nebraska | Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques |
-
1994
- 1994-10-27 US US08/329,892 patent/US6187579B1/en not_active Expired - Fee Related
- 1994-10-28 EP EP95921432A patent/EP0723585A1/en not_active Withdrawn
- 1994-10-28 AU AU26513/95A patent/AU679861B2/en not_active Ceased
- 1994-10-28 NZ NZ283995A patent/NZ283995A/en unknown
- 1994-10-28 WO PCT/US1995/006682 patent/WO1995020039A2/en not_active Application Discontinuation
- 1994-10-28 CA CA002174525A patent/CA2174525A1/en not_active Abandoned
- 1994-10-28 JP JP7517672A patent/JPH09504438A/en not_active Ceased
-
1997
- 1997-07-23 US US08/899,324 patent/US5945329A/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0085516A2 (en) * | 1982-01-22 | 1983-08-10 | Carlsberg Biotechnology Ltd. A/S | A process for enzymatic replacement of the B-30 amino acid in insulins |
WO1992002615A1 (en) * | 1990-08-09 | 1992-02-20 | Genentech, Inc. | Serine protease variants having peptide ligase activity |
Non-Patent Citations (5)
Title |
---|
J. BONGERS: "Comparison of enzymatic semisynthesis of peptide amides: human growth hormone releasing factor and analogs", BIOMED. BIOCHIM. ACTA, vol. 50, no. 10/11, pages 157 - 162 * |
J. WINTHER ET AL: "Increased hydrophobicity of the S1' binding site in carboxypeptidase Y obtained by site-directed mutagenesis", CARLSBERG RES. COMMUN., vol. 50, pages 273 - 284 * |
K OLESEN AND M. KIELLAND-BRANDT: "Altering substrate preference of carboxypeptidase Y by a novel strategy of mutagenesis eliminating wild type background", PROTEIN ENGINEERING, vol. 6, no. 4, pages 409 - 415 * |
R. SIEZEN ET AL: "Engineering of the substrate-binding region of the subtilisin-like cell-envelope proteinase of Lactococcus lactis", PROTEIN ENGINEERING, vol. 6, no. 8, pages 927 - 937 * |
U. MORTENSEN ET AL: "Site-directed mutagenesis on (serine) carboxypeptidase Y", BIOCHEMISTRY, vol. 33, pages 508 - 517 * |
Also Published As
Publication number | Publication date |
---|---|
US6187579B1 (en) | 2001-02-13 |
CA2174525A1 (en) | 1995-07-27 |
WO1995020039A2 (en) | 1995-07-27 |
US5945329A (en) | 1999-08-31 |
NZ283995A (en) | 2000-04-28 |
AU679861B2 (en) | 1997-07-10 |
EP0723585A1 (en) | 1996-07-31 |
AU2651395A (en) | 1995-08-08 |
JPH09504438A (en) | 1997-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1995020039A3 (en) | Customized proteases with altered transacylation activity | |
WO1995020039B1 (en) | Customized proteases with altered transacylation activity | |
Dufour et al. | Engineering nitrile hydratase activity into a cysteine protease by a single mutation | |
Grant et al. | A collagenolytic serine protease with trypsin-like specificity from the fiddler crab Uca pugilator | |
WO1999018228A3 (en) | Method for microbial production of amino acids of the aspartate and/or glutamate family and agents which can be used in said method | |
EP0308067A3 (en) | Alpha-amidating enzyme compositions and processes for their production and use | |
ES2077220T3 (en) | PROTEIN HYDROLYZES. | |
IE800694L (en) | Enzymatic producion of peptides. | |
MX9602397A (en) | Cocoa enzymatic treatment. | |
PH31435A (en) | Saccharin derivative proteolytic enzyme inhibitors. | |
TW225532B (en) | ||
BR9301489A (en) | PROCESSES FOR THE PREPARATION OF PURIFIED ENZYME FROM A FERMENTATION BRUSH AND FOR THE PREPARATION OF PURIFIED ALKALINE PROTEASE DERIVED FROM BACILLUS ALCALOPHILUS OR LICHENFORMIS BACILLUS FROM A FERMENTATION SOIL AND USE OF A PHASE OF PHASE. | |
EP0233013A3 (en) | Modified enzyme | |
Chatterjee et al. | Determination of Km and kcat for signal peptidase I using a full length secretory precursor, pro-OmpA-nuclease A | |
Kobayashi et al. | Functional analysis of the intramolecular chaperone: Mutational hot spots in the subtilisin pro-peptide and a secondsite suppressor mutation within the subtilisin molecule | |
US6576454B2 (en) | Modified enzymes and their use for peptide synthesis | |
CA2238313A1 (en) | Thermolabile uracil-dna-glycosylase, process for its production and use for removing uracil from dna | |
WO1988001298A3 (en) | Enzymatic membrane method for the synthesis and separation of peptides | |
AU1941597A (en) | Protein having cellulase activities and process for producing the same | |
CA2093950A1 (en) | Subtilisin-like protease from aspergillus niger | |
UA27132C2 (en) | TWO-FUNCTIONAL UROKINASE VARIANTS WITH BIASED FIBRINOLYTIC activity and thrombin-inhibitory action | |
Hannappel et al. | Limited proteolysis of liver and muscle aldolases: effects of subtilisin, cathepsin B, and Staphylococcus aureus protease | |
AU5727099A (en) | A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme | |
TW257792B (en) | ||
IL118473A0 (en) | Staphylococcus aureus V8 protease genes coding therefor and a method for the production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE MW SD SZ AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE MW SD SZ AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995921432 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2174525 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 283995 Country of ref document: NZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1995921432 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995921432 Country of ref document: EP |